Literature DB >> 28597826

Pathology of Tuberculosis: How the Pathology of Human Tuberculosis Informs and Directs Animal Models.

Randall J Basaraba1, Robert L Hunter2.   

Abstract

Tuberculosis (TB) is a chronic inflammatory disease caused by the pathogenic bacterium Mycobacterium tuberculosis. A wide variety of host- and pathogen-associated variables influence the clinical manifestation of TB in different individuals within the human population. As a consequence, the characteristic granulomatous lesions that develop within the lung are heterogeneous in size and cellular composition. Due to the lack of appropriate tissues from human TB patients, a variety of animal models are used as surrogates to study the basic pathogenesis and to test experimental vaccines and new drug therapies. Few animal models mimic the clinical course and pathological response of M. tuberculosis seen in the naturally occurring disease in people. In particular, post-primary TB, which accounts for the majority of cases of active TB and is responsible for transmission between individuals via aerosol exposers, cannot be reproduced in animals and therefore cannot be adequately modeled experimentally. This article describes a new paradigm that explains the pathogenesis of post-primary TB in humans. This new evidence was derived from histological examination of tissues from patients with different stages of M. tuberculosis infection and that had not been treated with antimicrobial drugs. Gaining a better understanding of this unique stage of TB disease will lead to more effective treatment, diagnostic, and prevention strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28597826     DOI: 10.1128/microbiolspec.TBTB2-0029-2016

Source DB:  PubMed          Journal:  Microbiol Spectr        ISSN: 2165-0497


  11 in total

1.  Treatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.

Authors:  Vikram Saini; Nicole C Ammerman; Yong Seok Chang; Rokeya Tasneen; Richard E Chaisson; Sanjay Jain; Eric Nuermberger; Jacques H Grosset
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

Review 2.  The pathogenesis of post-primary tuberculosis. A game changer for vaccine development.

Authors:  Robert Hunter; Jeffrey Actor
Journal:  Tuberculosis (Edinb)       Date:  2019-04-26       Impact factor: 3.131

Review 3.  Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?

Authors:  Hazel M Dockrell; Helen McShane
Journal:  EBioMedicine       Date:  2022-04-12       Impact factor: 11.205

4.  Humanized Mouse Model Mimicking Pathology of Human Tuberculosis for in vivo Evaluation of Drug Regimens.

Authors:  Frida Arrey; Delia Löwe; Stefanie Kuhlmann; Peggy Kaiser; Pedro Moura-Alves; Gopinath Krishnamoorthy; Laura Lozza; Jeroen Maertzdorf; Tatsiana Skrahina; Alena Skrahina; Martin Gengenbacher; Geraldine Nouailles; Stefan H E Kaufmann
Journal:  Front Immunol       Date:  2019-01-31       Impact factor: 7.561

Review 5.  One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics.

Authors:  Hee-Jeong Yang; Decheng Wang; Xin Wen; Danielle M Weiner; Laura E Via
Journal:  Front Cell Infect Microbiol       Date:  2021-03-16       Impact factor: 5.293

6.  Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis.

Authors:  Ray Y Chen; Xiang Yu; Bronwyn Smith; Xin Liu; Jingcai Gao; Andreas H Diacon; Rodney Dawson; Michele Tameris; Hong Zhu; Yahong Qu; Ruanqing Zhang; Shouguo Pan; Xiaowei Jin; Lisa C Goldfeder; Ying Cai; Kriti Arora; Jing Wang; Joel Vincent; Stephanus T Malherbe; Friedrich Thienemann; Robert J Wilkinson; Gerhard Walzl; Clifton E Barry
Journal:  Lancet Microbe       Date:  2021-10

Review 7.  The Pathogenesis of Tuberculosis: The Early Infiltrate of Post-primary (Adult Pulmonary) Tuberculosis: A Distinct Disease Entity.

Authors:  Robert L Hunter
Journal:  Front Immunol       Date:  2018-09-19       Impact factor: 7.561

Review 8.  The Bovine Tuberculoid Granuloma.

Authors:  Mitchell V Palmer; Carly Kanipe; Paola M Boggiatto
Journal:  Pathogens       Date:  2022-01-04

9.  Early Lesion of Post-Primary Tuberculosis: Subclinical Driver of Disease and Target for Vaccines and Host-Directed Therapies.

Authors:  Robert E Brown; Robert L Hunter
Journal:  Pathogens       Date:  2021-12-02

10.  Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice.

Authors:  Andrea C Bohrer; Ehydel Castro; Zhidong Hu; Artur T L Queiroz; Claire E Tocheny; Maike Assmann; Shunsuke Sakai; Christine Nelson; Paul J Baker; Hui Ma; Lin Wang; Wen Zilu; Elsa du Bruyn; Catherine Riou; Keith D Kauffman; Ian N Moore; Franca Del Nonno; Linda Petrone; Delia Goletti; Adrian R Martineau; David M Lowe; Mark R Cronan; Robert J Wilkinson; Clifton E Barry; Laura E Via; Daniel L Barber; Amy D Klion; Bruno B Andrade; Yanzheng Song; Ka-Wing Wong; Katrin D Mayer-Barber
Journal:  J Exp Med       Date:  2021-08-04       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.